Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
- PMID: 34071306
- PMCID: PMC8198046
- DOI: 10.3390/ijms22115775
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Abstract
The complex interaction between glioblastoma and its microenvironment has been recognized for decades. Among various immune profiles, the major population is tumor-associated macrophage, with microglia as its localized homolog. The present definition of such myeloid cells is based on a series of cell markers. These good sentinel cells experience significant changes, facilitating glioblastoma development and protecting it from therapeutic treatments. Huge, complicated mechanisms are involved during the overall processes. A lot of effort has been dedicated to crack the mysterious codes in macrophage/microglia recruiting, activating, reprogramming, and functioning. We have made our path. With more and more key factors identified, a lot of new therapeutic methods could be explored to break the ominous loop, to enhance tumor sensitivity to treatments, and to improve the prognosis of glioblastoma patients. However, it might be a synergistic system rather than a series of clear, stepwise events. There are still significant challenges before the light of truth can shine onto the field. Here, we summarize recent advances in this field, reviewing the path we have been on and where we are now.
Keywords: glioblastoma; glioblastoma-associated macrophages/microglia; macrophage; microglia; tumor microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Pimenta M.G., Otero Á., Guzman D.A.A., Pascual-Argente D., Martín L.R., Sousa-Casasnovas P., García-Martin A., de Oca J.C.R.M., Villaseñor J.J.M., Carretero L.T., et al. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome. Brain Pathol. 2021;31:365–380. doi: 10.1111/bpa.12927. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
